MTS Health Partners Reviews
New York, NY · Founded 1999
- Type
- Industry specialist
- HQ
- New York, NY
- Founded
- 1999
- Deal size
- $25M-$500M
- Focus
- Healthcare, Life Sciences
- Website
- mtshealth.com
- Curtis LaneCo-Founder, Senior Managing Director
MTS Health Partners is a industry specialist headquartered in New York, NY and founded in 1999. The firm focuses on Healthcare, Life Sciences and typically advises on transactions in the $25M-$500M range. Key dealmakers include Curtis Lane (Co-Founder, Senior Managing Director). Read founder-verified reviews of MTS Health Partners below, from founders who hired the firm as their sell-side advisor whether the deal closed or not.
What to know about MTS Health Partners
MTS Health Partners has built its franchise in Healthcare, Life Sciences, where founders running a sale process often turn to firms with deep sector pattern recognition. The senior bench, anchored by Curtis Lane, sets the tone for how engagements run from the first call through whatever outcome the process produces. Founders evaluating MTS Health Partners typically compare it against other industry specialist houses with similar sector emphasis.
Deal sweet spot at MTS Health Partners sits in the $25M-$500M band. That target range shapes everything: which buyers get the call, how the process is paced, and how the firm allocates senior banker attention. Founders working with MTS Health Partners should expect a process tuned to that band; founders far below or above it sometimes find a better fit elsewhere.
Geography matters more than founders expect. MTS Health Partners operates out of New York, NY, and its strongest buyer-side relationships tend to cluster around that orbit. For sellers running a global process, that can be either an advantage (concentrated relationships) or a constraint (thinner reach in other regions). Founders should ask directly: which buyers have you placed with in the last 24 months, and where are they.
Reviews
Reviews unlock once 5 verified founders have rated this firm. Be the first to break the silence.
Frequently asked questions
- Who can review MTS Health Partners?
- Any founder who hired MTS Health Partners as their sell-side advisor and ran an M&A process with them, regardless of whether the deal ultimately closed. How a banker behaves when a deal does not close is just as important as when it does, and both outcomes are welcome.
- Has MTS Health Partners been reviewed by founders?
- MTS Health Partners appears in the BankerNotes directory. Reviews from verified founders who hired the firm unlock publicly once five founders have submitted ratings. Until that threshold is reached, reviews are pending and not displayed.
- Where is MTS Health Partners headquartered?
- MTS Health Partners is headquartered in New York, NY. The firm was founded in 1999.
- What kinds of deals does MTS Health Partners work on?
- MTS Health Partners focuses on Healthcare, Life Sciences. Typical transaction size falls in the $25M-$500M range.
- Who are the key dealmakers at MTS Health Partners?
- Senior dealmakers include Curtis Lane (Co-Founder, Senior Managing Director). Founders running a process should expect to interact most with the named partner or managing director assigned to the deal.
- How does BankerNotes verify reviews of MTS Health Partners?
- Every review on BankerNotes is submitted by a founder who confirms they hired the firm as their sell-side advisor. We verify the reviewer privately using work email, LinkedIn, and approximate engagement timing. The verified identity is never published. Only the rating, written review, and a generic sector label appear on the public page.
Other Healthcare M&A advisors founders compare with MTS Health Partners
More context for MTS Health Partners
Last updated: October 11, 2025